BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11512598)

  • 1. Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance.
    Diamond T; Levy S; Smith A; Day P; Manoharan A
    Intern Med J; 2001 Jul; 31(5):272-8. PubMed ID: 11512598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone remodelation markers are useful in the management of monoclonal gammopathies.
    Hernández JM; Suquía B; Queizan JA; Fisac RM; Sanchez JJ; Fernández-Calvo FJ; García-Sanz R; Olivier C; Bárez A; Calmuntia MJ; García-Frade J; Portero JA; López R; Aguilera C; Navajo JA; San-Miguel JF
    Hematol J; 2004; 5(6):480-8. PubMed ID: 15570289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers of bone formation in patients with plasma cell dyscrasias and benign osteoporosis.
    Woitge HW; Horn E; Keck AV; Auler B; Seibel MJ; Pecherstorfer M
    Clin Chem; 2001 Apr; 47(4):686-93. PubMed ID: 11274019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma.
    Woitge HW; Pecherstorfer M; Horn E; Keck AV; Diel IJ; Bayer P; Ludwig H; Ziegler R; Seibel MJ
    Br J Cancer; 2001 Feb; 84(3):344-51. PubMed ID: 11161399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contribution to the evaluation of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and in individual clinical stages of multiple myeloma].
    Scudla V; Petrová P; Minarík J; Pika T; Budíková M; Bacovský J; Repovský S
    Vnitr Lek; 2010 Jun; 56(6):591-601. PubMed ID: 20681472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
    Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
    Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gammopathies of indeterminant significance and osteoporosis: association or coincidence?].
    Laroche M; Rolland Y; Tackzuck J; Constantin A; Salles JP; Mazières B
    Presse Med; 1998 Mar; 27(10):461-4. PubMed ID: 9767972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: quantification by urinary pyridinium cross-links of collagen.
    Pecherstorfer M; Seibel MJ; Woitge HW; Horn E; Schuster J; Neuda J; Sagaster P; Köhn H; Bayer P; Thiébaud D; Ludwig H
    Blood; 1997 Nov; 90(9):3743-50. PubMed ID: 9345061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of serum IL-6 level in monoclonal gammopathies.
    DuVillard L; Guiguet M; Casasnovas RO; Caillot D; Monnier-Zeller V; Bernard A; Guy H; Solary E
    Br J Haematol; 1995 Feb; 89(2):243-9. PubMed ID: 7873373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of signalling pathways in myeloma bone disease with regard to activity of the disease, extent of skeletal involvement and correlation to bone turnover markers.
    Minarik J; Hermanova Z; Petrova P; Hrbek J; Zapletalova J; Krhovska P; Flodr P; Pika T; Bacovsky J; Flodrova P; Herman M; Scudla V
    Eur J Haematol; 2016 Aug; 97(2):201-7. PubMed ID: 26613192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The search for meaning in monoclonal protein. Is it multiple myeloma or monoclonal gammopathy of undetermined significance?
    Brigden ML
    Postgrad Med; 1999 Aug; 106(2):135-42; quiz 185. PubMed ID: 10456045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring markers of bone turnover in multiple myeloma].
    Spicka I; Spacek P; Hulejová H; Procházka B; Cieslar P; Chrz M; Válková V; Klener P
    Vnitr Lek; 1999 Aug; 45(8):463-7. PubMed ID: 11045145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma.
    Jakob C; Zavrski I; Heider U; Brux B; Eucker J; Langelotz C; Sinha P; Possinger K; Sezer O
    Eur J Haematol; 2002 Jul; 69(1):37-42. PubMed ID: 12270060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H; Wierzbowska A; Robak T
    Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma.
    Sezer O; Jakob C; Eucker J; Niemöller K; Gatz F; Wernecke K; Possinger K
    Eur J Haematol; 2001 Feb; 66(2):83-8. PubMed ID: 11168514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of the bone marrow plasma cell cytoplasmic light chain ratio in differentiating between multiple myeloma and monoclonal gammopathy of undetermined significance.
    Majumdar G; Grace RJ; Singh AK; Slater NG
    Leuk Lymphoma; 1992 Dec; 8(6):491-3. PubMed ID: 1297481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone remodelling in monoclonal gammopathies of uncertain significance, symptomatic and nonsymptomatic myeloma.
    Laroche M; Attal M; Dromer C
    Clin Rheumatol; 1996 Jul; 15(4):347-52. PubMed ID: 8853167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and outcome of multiple myeloma arising from the transformation of a monoclonal gammapathy of undetermined significance.
    Patriarca F; Fanin R; Silvestri F; Candoni A; Zaja F; Sperotto A; Geromin A; Baccarani M
    Leuk Lymphoma; 1999 Aug; 34(5-6):591-6. PubMed ID: 10492084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell frequency and serum cytokine levels in monoclonal gammopathies: correlation of bone marrow granular lymphocytes to prognosis.
    Sawanobori M; Suzuki K; Nakagawa Y; Inoue Y; Utsuyama M; Hirokawa K
    Acta Haematol; 1997; 98(3):150-4. PubMed ID: 9352746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients.
    Zdzisińska B; Wejksza K; Walter-Croneck A; Turski WA; Kandefer-Szerszeń M
    Leuk Res; 2010 Jan; 34(1):38-45. PubMed ID: 19596432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.